Physician

Sydney L Tyson, M.D.

According to 2025 Medicare claims, Sydney Tyson, M.D. (NPI: 1639113665) practices ophthalmology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 08361-7802. Tyson is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Tyson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,263 traditional Medicare patients, billed 5,293 HCPCS/CPT codes, and received $421,845 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,507 prescription claims across 488 beneficiaries totaling $295,747 in drug costs, led by Restasis (Cyclosporine). 2020 DME data shows 28 claims. Open Payments data shows 31 records totaling $4,095. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $925,558 to $421,845. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,308	6,905	$925,558
2016	2,300	6,778	$900,357
2017	2,283	7,125	$914,653
2018	2,056	6,775	$797,308
2019	1,789	6,407	$688,456
2020	1,422	5,290	$445,275
2021	1,426	4,840	$503,248
2022	1,378	5,565	$554,678
2023	1,275	5,234	$462,641
2024	1,263	5,293	$421,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	458	1,604	$263,511
2016	413	1,460	$267,745
2017	424	1,496	$312,031
2018	401	1,551	$354,078
2019	352	1,373	$328,694
2020	307	1,212	$309,621
2021	351	1,265	$347,155
2022	437	1,627	$389,961
2023	402	1,291	$327,788
2024	488	1,507	$295,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	63	$4,459
2016	76	76	$4,991
2017	140	140	$9,397
2018	162	162	$10,128
2019	99	100	$6,318
2020	28	28	$1,867
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	189	322	$470
66821	Removal of recurring cataract in lens capsule using a laser	124	174	$273
92014	Established patient complete exam of visual system	813	893	$94
92012	Established patient problem focused exam of visual system	222	279	$63
92136	Measurement of corneal curvature and depth of eye	253	378	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	42	3,525	$70,611
Cyclosporine	Cyclosporine	63	4,710	$53,788
Xiidra	Lifitegrast	22	1,740	$37,178
Combigan	Brimonidine Tartrate/Timolol	37	1,976	$15,895
Lumigan	Bimatoprost	32	1,817	$15,145

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$4,095	Carl Zeiss Meditec, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sydney L. Tyson, M.D.?

Tedicare shows public-source Medicare data for Sydney L. Tyson, M.D. (NPI 1639113665), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sydney L. Tyson, M.D. have ACO affiliation data?

Sydney L. Tyson, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Sydney L. Tyson, M.D.?

Sydney L. Tyson, M.D. is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Sydney L. Tyson, M.D. have Open Payments data?

Sydney L. Tyson, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.